Grace Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2018 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Grace Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2018 to Q3 2024.
  • Grace Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 13, 2024 was 10.1M shares, a 7.88% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 10.1M +740K +7.88% Nov 13, 2024 10-Q 2024-11-13
Q2 2024 9.4M -35.2M -78.9% Jun 21, 2024 10-K 2024-06-21
Q4 2023 9.4M -35.2M -78.9% Feb 9, 2024 10-Q 2024-02-12
Q3 2023 9.4M -35.2M -78.9% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 44.6M +173K +0.39% Jun 23, 2023 10-K 2023-06-23
Q4 2022 44.6M +325K +0.73% Feb 13, 2023 10-Q 2023-02-14
Q3 2022 44.6M +325K +0.73% Nov 14, 2022 10-Q 2022-11-14
Q2 2022 44.4M -164M -78.7% Jun 21, 2022 10-K 2022-06-21
Q4 2021 44.3M -135M -75.3% Feb 14, 2022 10-Q 2022-02-14
Q3 2021 44.3M Nov 10, 2021 10-Q 2021-11-10
Q2 2021 208M +116M +125% Jun 22, 2021 10-K 2021-06-22
Q4 2020 179M Feb 9, 2021 10-Q 2021-02-09
Q2 2020 92.5M Jun 26, 2020 10-K 2020-06-29
Q1 2019 78.1M +52.5M +205% Mar 31, 2019 20-F 2019-06-26
Q1 2018 25.6M Mar 31, 2018 20-F 2018-06-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.